Sharechat Logo

F&P Healthcare files US patent infringement against rival ResMed

Tuesday 16th August 2016

Text too small?

Fisher & Paykel Healthcare, the medical devices maker, has filed a patent infringement lawsuit in the US against ResMed, claiming its rival used its technology in its breathing masks and air flow products.

Auckland-based F&P Healthcare said it is "seeking all available remedies, including damages and injunctive relief" in its proceedings in the US District Court for the Central District of California. The lawsuit says ResMed's "AirSense 10 and AirCurve 10 range of flow generator products, ClimateLineAir heated air tubing for use with such flow generator products and Swift LT and Swift FX masks, infringe patents held by Fisher & Paykel Healthcare".

“Fisher & Paykel Healthcare has invested substantial resources in the research and development of its technologies over the past 45 years," said managing director Lewis Gradon, in a statement. "The company has protected that investment through the development of a significant portfolio of more than 1,400 issued and pending patents and takes infringement of its intellectual property rights very seriously.”

F&P Healthcare shares fell 0.5 percent to $10.70 in early trading this morning on the NZX and have gained 20 percent this year. The stock is rated a 'buy' based on the consensus of seven analysts surveyed by Reuters with a median price target of $10.75. ResMed shares last traded at US$70.60 and have gained 32 percent this year.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

NZAS Sign Long Term Contracts
Amended - IFT230 Maturity and Exchange for IFT350
Synlait forecast milk price update
Chorus submits 2023 fibre regulatory report
Infratil Infrastructure Bond Exchange Offer opens
May 31st Morning Report
NZAS and Mercury sign long-term agreement, creating opportunity for future investment in renewables
Meridian and NZAS sign long term contracts
ArborGen Holdings Results for Year Ended 31 March 2024
BAI - Full unaudited results to 31 March 2024